Nicholas Grund

Companies

• Akebia Therapeutics, Inc.Chief Commercial Officer Jan 18, 2024 to now¹
• AMAG PharmaceuticalsChief Commercial Officer Jan 5, 2016 to Mar 5, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkebia Therapeutics, Inc. AKBA561,750 shares³$396.5K at $0.71Feb 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 2, 2026Sold 31,244 shares at $1.39 of Akebia Therapeutics, Inc.³
• Feb 2, 2026Sold 53,585 shares at $1.39 of Akebia Therapeutics, Inc.³
• Jan 30, 2026Granted 204,000 shares of Akebia Therapeutics, Inc.⁴
• Feb 3, 2025Sold 55,621 shares at $2.10 of Akebia Therapeutics, Inc.⁵
• Jan 31, 2025Granted 194,900 shares of Akebia Therapeutics, Inc.⁵
• Jan 31, 2024Granted 303,300 shares of Akebia Therapeutics, Inc.⁶